Please assess the completion status of the following clinical trial:

Trial Title: Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Admitted to pediatric intensive care unit and have the diagnosis of acute respiratory failure~* 44 weeks post conceptional age to 16 years of age~* Oxygenation Index (OI) \>=12 cm H2O/mmHg (as determined by two separate measurement taken 30 minutes to 4 hours apart)~* Recent chest x-ray (within 24 hours) showing at least unilateral infiltrations~* Mechanically ventilated \<= 7 days~Exclusion criteria:~* Immunocompromised~* Received a bone marrow transplant~* Active oncological condition~* Persistent right to left intracardiac shunt~* Cardiovascular surgery within the last 14 days~* Status asthmaticus~* Decision by primary care physician not to provide full support~* Received treatment with nitric oxide for inhalation or other investigational medications within 24 hours prior to study initiation, participating in surfactant trials~* Chronically ventilated~* Pregnant

- Gender: ALL
- Minimum Age: None
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- 2 (Type: PLACEBO_COMPARATOR): Nitrogen gas
- 1 (Type: EXPERIMENTAL): Inhaled Nitric Oxide

Based on this trial design, predict the completion outcome and termination type (if applicable).